MKR mice are resistant to the metabolic actions of both insulin and adiponectin: Discordance between insulin resistance and adiponectin responsiveness

Chul Hee Kim, Patricia Pennisi, Hong Zhao, Shoshana Yakar, Jeanne B. Kaufman, Kenjiro Iganaki, Joseph Shiloach, Philipp E. Scherer, Michael J. Quon, Derek LeRoith

Research output: Contribution to journalArticle

Abstract

Most rodent models of insulin resistance are accompanied by decreased circulating adiponectin levels. Adiponectin treatment improves the metabolic phenotype by increasing fatty acid oxidation in skeletal muscle and suppressing hepatic glucose production. Muscle IGF-I receptor (IGF-IR)-lysine-arginine (MKR) mice expressing dominant-negative mutant IGF-IRs in skeletal muscle are diabetic with insulin resistance in muscle, liver, and adipose tissue. Adiponectin levels are elevated in MKR mice, suggesting an unusual discordance between insulin resistance and adiponectin responsiveness. Therefore, we investigated the metabolic actions of adiponectin in MKR mice. MKR and ob/ob mice were treated both acutely (28 μg/g) and chronically (for 2 wk) with full-length adiponectin. Acute hypoglycemic effects of adiponectin were evident only in ob/ob mice but not in MKR mice. Chronic adiponectin treatment significantly improved both insulin sensitivity and glucose tolerance in ob/ob but not in MKR mice. Adiponectin receptor mRNA levels and adiponectin-stimulated phosphorylation of AMPK in skeletal muscle and liver were similar among MKR, wild-type, and ob/ob mice. Thus MKR mice are adiponectin resistant despite normal expression of adiponectin receptors and normal AMPK phosphorylation in muscle and liver. MKR mice may be a useful model for dissecting relationships between insulin resistance and adiponectin action in regulation of glucose homeostasis.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume291
Issue number2
DOIs
StatePublished - 2006

Fingerprint

Adiponectin
Insulin Resistance
Insulin
Muscle
Adiponectin Receptors
Liver
Phosphorylation
Skeletal Muscle
AMP-Activated Protein Kinases
Glucose
Muscles
IGF Type 1 Receptor
Hypoglycemic Agents
Lysine
Arginine
Adipose Tissue
Rodentia
Homeostasis
Fatty Acids
Tissue

Keywords

  • Adiponectin resistance
  • Muscle insulin-like growth factor-I receptor-lysine-arginine mouse

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

MKR mice are resistant to the metabolic actions of both insulin and adiponectin : Discordance between insulin resistance and adiponectin responsiveness. / Kim, Chul Hee; Pennisi, Patricia; Zhao, Hong; Yakar, Shoshana; Kaufman, Jeanne B.; Iganaki, Kenjiro; Shiloach, Joseph; Scherer, Philipp E.; Quon, Michael J.; LeRoith, Derek.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 291, No. 2, 2006.

Research output: Contribution to journalArticle

Kim, Chul Hee ; Pennisi, Patricia ; Zhao, Hong ; Yakar, Shoshana ; Kaufman, Jeanne B. ; Iganaki, Kenjiro ; Shiloach, Joseph ; Scherer, Philipp E. ; Quon, Michael J. ; LeRoith, Derek. / MKR mice are resistant to the metabolic actions of both insulin and adiponectin : Discordance between insulin resistance and adiponectin responsiveness. In: American Journal of Physiology - Endocrinology and Metabolism. 2006 ; Vol. 291, No. 2.
@article{2897f0d5433547279cf913e6dee1bf43,
title = "MKR mice are resistant to the metabolic actions of both insulin and adiponectin: Discordance between insulin resistance and adiponectin responsiveness",
abstract = "Most rodent models of insulin resistance are accompanied by decreased circulating adiponectin levels. Adiponectin treatment improves the metabolic phenotype by increasing fatty acid oxidation in skeletal muscle and suppressing hepatic glucose production. Muscle IGF-I receptor (IGF-IR)-lysine-arginine (MKR) mice expressing dominant-negative mutant IGF-IRs in skeletal muscle are diabetic with insulin resistance in muscle, liver, and adipose tissue. Adiponectin levels are elevated in MKR mice, suggesting an unusual discordance between insulin resistance and adiponectin responsiveness. Therefore, we investigated the metabolic actions of adiponectin in MKR mice. MKR and ob/ob mice were treated both acutely (28 μg/g) and chronically (for 2 wk) with full-length adiponectin. Acute hypoglycemic effects of adiponectin were evident only in ob/ob mice but not in MKR mice. Chronic adiponectin treatment significantly improved both insulin sensitivity and glucose tolerance in ob/ob but not in MKR mice. Adiponectin receptor mRNA levels and adiponectin-stimulated phosphorylation of AMPK in skeletal muscle and liver were similar among MKR, wild-type, and ob/ob mice. Thus MKR mice are adiponectin resistant despite normal expression of adiponectin receptors and normal AMPK phosphorylation in muscle and liver. MKR mice may be a useful model for dissecting relationships between insulin resistance and adiponectin action in regulation of glucose homeostasis.",
keywords = "Adiponectin resistance, Muscle insulin-like growth factor-I receptor-lysine-arginine mouse",
author = "Kim, {Chul Hee} and Patricia Pennisi and Hong Zhao and Shoshana Yakar and Kaufman, {Jeanne B.} and Kenjiro Iganaki and Joseph Shiloach and Scherer, {Philipp E.} and Quon, {Michael J.} and Derek LeRoith",
year = "2006",
doi = "10.1152/ajpendo.00319.2005",
language = "English (US)",
volume = "291",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - MKR mice are resistant to the metabolic actions of both insulin and adiponectin

T2 - Discordance between insulin resistance and adiponectin responsiveness

AU - Kim, Chul Hee

AU - Pennisi, Patricia

AU - Zhao, Hong

AU - Yakar, Shoshana

AU - Kaufman, Jeanne B.

AU - Iganaki, Kenjiro

AU - Shiloach, Joseph

AU - Scherer, Philipp E.

AU - Quon, Michael J.

AU - LeRoith, Derek

PY - 2006

Y1 - 2006

N2 - Most rodent models of insulin resistance are accompanied by decreased circulating adiponectin levels. Adiponectin treatment improves the metabolic phenotype by increasing fatty acid oxidation in skeletal muscle and suppressing hepatic glucose production. Muscle IGF-I receptor (IGF-IR)-lysine-arginine (MKR) mice expressing dominant-negative mutant IGF-IRs in skeletal muscle are diabetic with insulin resistance in muscle, liver, and adipose tissue. Adiponectin levels are elevated in MKR mice, suggesting an unusual discordance between insulin resistance and adiponectin responsiveness. Therefore, we investigated the metabolic actions of adiponectin in MKR mice. MKR and ob/ob mice were treated both acutely (28 μg/g) and chronically (for 2 wk) with full-length adiponectin. Acute hypoglycemic effects of adiponectin were evident only in ob/ob mice but not in MKR mice. Chronic adiponectin treatment significantly improved both insulin sensitivity and glucose tolerance in ob/ob but not in MKR mice. Adiponectin receptor mRNA levels and adiponectin-stimulated phosphorylation of AMPK in skeletal muscle and liver were similar among MKR, wild-type, and ob/ob mice. Thus MKR mice are adiponectin resistant despite normal expression of adiponectin receptors and normal AMPK phosphorylation in muscle and liver. MKR mice may be a useful model for dissecting relationships between insulin resistance and adiponectin action in regulation of glucose homeostasis.

AB - Most rodent models of insulin resistance are accompanied by decreased circulating adiponectin levels. Adiponectin treatment improves the metabolic phenotype by increasing fatty acid oxidation in skeletal muscle and suppressing hepatic glucose production. Muscle IGF-I receptor (IGF-IR)-lysine-arginine (MKR) mice expressing dominant-negative mutant IGF-IRs in skeletal muscle are diabetic with insulin resistance in muscle, liver, and adipose tissue. Adiponectin levels are elevated in MKR mice, suggesting an unusual discordance between insulin resistance and adiponectin responsiveness. Therefore, we investigated the metabolic actions of adiponectin in MKR mice. MKR and ob/ob mice were treated both acutely (28 μg/g) and chronically (for 2 wk) with full-length adiponectin. Acute hypoglycemic effects of adiponectin were evident only in ob/ob mice but not in MKR mice. Chronic adiponectin treatment significantly improved both insulin sensitivity and glucose tolerance in ob/ob but not in MKR mice. Adiponectin receptor mRNA levels and adiponectin-stimulated phosphorylation of AMPK in skeletal muscle and liver were similar among MKR, wild-type, and ob/ob mice. Thus MKR mice are adiponectin resistant despite normal expression of adiponectin receptors and normal AMPK phosphorylation in muscle and liver. MKR mice may be a useful model for dissecting relationships between insulin resistance and adiponectin action in regulation of glucose homeostasis.

KW - Adiponectin resistance

KW - Muscle insulin-like growth factor-I receptor-lysine-arginine mouse

UR - http://www.scopus.com/inward/record.url?scp=33745864810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745864810&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00319.2005

DO - 10.1152/ajpendo.00319.2005

M3 - Article

C2 - 16507604

AN - SCOPUS:33745864810

VL - 291

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 2

ER -